Why Randox is securing its data with Valarian
Max Buchan sat down with Joseph Clifford, Chief Technical Officer of Randox, the UK’s largest diagnostics company, to talk about the multi-year deal between the two British companies.
Under the agreement, Randox will deploy its data and analysis into Valarian’s secure digital architecture, initially focusing on manufacturing before expanding into healthcare in December. Acting as a sovereign execution layer, Valarian’s ACRA technology allows organisations to securely use and manage sensitive data without relinquishing ownership or control to external providers.
Joseph Clifford, Chief Technical Officer of Randox, said:
“We’re entrusted with a large amount of patient data, and our patients are of the utmost importance to us. Ensuring their data is secure is first and foremost, and we’ve seen the Valarian product as a key fit for peace of mind in that area.”
Max Buchan, CEO and founder of Valarian, said:
“Britain has some of the best technology and healthcare companies in the world. Randox is a fantastic example of that, and I’m proud to be partnering with another UK business to help secure the sensitive data underpinning our healthcare sector.”
Read the announcement: We’re partnering with Randox to bring sovereign technology to healthcare.
